Efficacy of Tofacitinib for the Treatment of Psoriatic Arthritis: Pooled Analysis of Two Phase 3 Studies

Efficacy of Tofacitinib for the Treatment of Psoriatic Arthritis: Pooled Analysis of Two Phase 3 Studies

Abstract Introduction Tofacitinib is an oral Janus kinase inhibitor for the treatment of psoriatic arthritis (PsA). This post hoc analysis assessed the efficacy of tofacitinib using pooled data from two phase 3 studies of patients with active PsA. Methods Data were pooled from OPAL Broaden (NCT01877...

Full description

Bibliographic Details
Main Authors: Peter Nash, Laura C. Coates, Roy Fleischmann, Kim A. Papp, Juan Jesus Gomez-Reino, Keith S. Kanik, Cunshan Wang, Joseph Wu, Sujatha Menon, Thijs Hendrikx, William C. Ports
Format: Article
Language:English
Published: Adis, Springer Healthcare 2018-11-01
Series:Rheumatology and Therapy
Subjects:
Janus kinase inhibitor
Psoriatic arthritis
Spondyloarthritis
Tofacitinib
Treatment
Online Access:http://link.springer.com/article/10.1007/s40744-018-0131-5

Internet

http://link.springer.com/article/10.1007/s40744-018-0131-5

Similar Items